A license grants the right to use a technology; it does not transfer ownership
Universities and research institutes rarely take a technology all the way to a finished product themselves. Most research results reach the market through someone else’s factory, brand, and distribution network, and the agreement that makes this possible is the license.
This is because a license and an assignment of intellectual property rights are not the same transaction.
An assignment means that the owner permanently transfers the intellectual property rights to another party. Once this is done, the university or research institute generally loses the ability to control or exploit those rights, unless the agreement reserves specific rights, obligations or limitations.
A license means that the licensor keeps ownership of the intellectual property rights or know-how and grants the licensee the right to use them within a defined scope and under defined conditions, in exchange for compensation. Ownership of the intellectual property does not change hands.
A license only becomes valuable when its scope, financial terms, and obligations match what the licensee is actually able and willing to do with the technology and keep doing for as long as the agreement runs.
The licensed subject matter must be defined precisely: a patent or patent application, know-how, software, data, research material, technical documentation or a combination of these assets. A patent license alone may not be sufficient if implementation depends on undisclosed know-how held by the research team.
Signing the agreement is only the beginning
In many technology transfer offices, a license is judged a success once the deal has closed.
- Was a license agreement signed?
- Did it generate an upfront payment?
- Was the technology formally handed over to the licensee?
In commercialization, the value of a license is judged differently.
- Does the licensee have the capability and the incentive to actually develop the technology?
- Does the scope of the license such as field of use, territory, and exclusivity, match what this particular licensee can realistically deliver?
- Do the financial terms reflect the risk and investment still required to bring the technology to market?
- What happens if the licensee fails to develop the technology within a reasonable time?
- Who owns improvements made during development, and on what terms?
- Can performance be monitored, reported, and enforced for the life of the agreement?
The right structure for a license depends on what exactly is being licensed, to whom, at what stage of technology development and in which market. A handful of patterns recur in practice.
Common types of license
| Exclusive license | The licensee is the only party permitted to use the technology within the agreed scope, excluding other licensees and often the licensor itself. Exclusivity typically comes with higher fees, stronger development obligations and the licensor’s right to limit or withdraw exclusivity if the technology is not developed. The university or research institute gives up the option of licensing the same technology to anyone else within the licensed scope. |
| Non-exclusive license | The university can license the same technology to several parties at the same time. This works well when the technology has broad application such as a research tool, an analytical method, a software component, and no single licensee needs exclusivity to justify the investment. |
|
Field of use license |
The right to use the technology is limited to a defined application or industry, while the university retains the ability to license the same technology in other fields. A platform developed for medical diagnostics may be licensed separately for veterinary or industrial use. |
|
Territorial license |
The scope of the license is limited to a defined country or region, allowing the university or research institute to enter separate agreements with partners better positioned to operate in other markets. |
|
Sublicensable license |
The licensee may grant sublicenses to third parties only if the agreement or the licensor expressly permits it. This matters for spin-offs and platform technologies building their own network of implementation partners, and it requires clear rules for sharing sublicense revenue and preserving the licensor’s control over how the technology is deployed. |
The right structure depends on the maturity of the technology, how competitive the market is, the licensee’s ability to develop the technology further and whether the licensor can grant the planned scope of rights. Earlier agreements, co-owners, public funding, obligations to partners and confidential know-how may limit licensing freedom. The same technology can be licensed on very different terms, depending on who receives it and for what purpose.
What determines whether a license creates value?
Four elements usually need to be addressed together.
1. Scope and exclusivity
Field of use, territory, and the degree of exclusivity must match what the licensee actually intends and is able to deliver. Granting a broad scope to a party without the resources to use it locks the technology away from other potential partners.
2. Financial terms
Upfront fees, running royalties, and milestone payments should reflect the stage of development and the risk the licensee still carries. Fees set too high early on can discourage further investment by the licensee. Royalties set too low may fail to reflect the value the technology creates once it reaches the market.
3. Diligence obligations and performance monitoring
The agreement should set specific development milestones, deadlines, reporting obligations, the licensor’s audit rights and the consequences of non-performance, such as loss of exclusivity, narrowing of the licensed scope or termination. Without these provisions, a technology can end up shelved (formally licensed but never developed) and the university or research institute may have limited ability to recover the rights.
4. Improvements and future intellectual property
New solutions and improvements typically emerge during development. The agreement must specify who owns them, whether the licensor receives access to them through a grant back clause, and how the research team's freedom to continue research, publish and commercialize other applications is preserved.
A license is not a single transaction but a relationship that unfolds over time, in which both sides carry risk: the licensor gives up exclusive control over the technology within the licensed scope, and the licensee commits resources without any guarantee of market success.
Successful licensing does not mean signing as many agreements as possible. It means matching scope, financial terms, and development obligations to the capability and motivation of a specific licensee, so that the technology actually reaches users rather than sitting as an entry in a contracts register.
